136 related articles for article (PubMed ID: 24344026)
1. Determination of matrix metalloproteinase 9 (MMP-9) protein expression in laryngeal squamous cell carcinomas based on digital image analysis.
Papadas TA; Naxakis SS; Mastronikolis NS; Stathas T; Karabekos NCh; Tsiambas E
J BUON; 2013; 18(4):977-81. PubMed ID: 24344026
[TBL] [Abstract][Full Text] [Related]
2. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of PTEN Expression in Laryngeal Squamous Cell Carcinoma Based on Tissue Microarray Digital Analysis.
Mastronikolis NS; Tsiambas E; Papadas TA; Karameris A; Ragos V; Peschos D; Mastronikolis SN; Papadas AT; Liatsos C; Armata IE; Fotiades PP
Anticancer Res; 2017 Oct; 37(10):5521-5524. PubMed ID: 28982865
[TBL] [Abstract][Full Text] [Related]
4. Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas.
Krecicki T; Fraczek M; Jelen M; Podhorska M; Szkudlarek T; Zatonski T
Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):494-7. PubMed ID: 12739032
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis.
Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
Clin Cancer Res; 2004 May; 10(9):3110-6. PubMed ID: 15131051
[TBL] [Abstract][Full Text] [Related]
6. Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.
Riedel F; Götte K; Schwalb J; Bergler W; Hörmann K
Int J Oncol; 2000 Dec; 17(6):1099-105. PubMed ID: 11078794
[TBL] [Abstract][Full Text] [Related]
7. Expression of type IV collagen, metalloproteinase-2, metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in laryngeal squamous cell carcinomas.
Cao XL; Xu RJ; Zheng YY; Liu J; Teng YS; Li Y; Zhu J
Asian Pac J Cancer Prev; 2011; 12(12):3245-9. PubMed ID: 22471461
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
Samantaray S; Sharma R; Chattopadhyaya TK; Gupta SD; Ralhan R
J Cancer Res Clin Oncol; 2004 Jan; 130(1):37-44. PubMed ID: 14569466
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of matrix metalloproteinase-20 overexpression in laryngeal squamous cell carcinoma.
Liu Y; Li Y; Liu Z; Zhang L; Anniko M; Duan M
Acta Otolaryngol; 2011 Jul; 131(7):769-73. PubMed ID: 21466263
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness.
Culhaci N; Metin K; Copcu E; Dikicioglu E
BMC Cancer; 2004 Aug; 4():42. PubMed ID: 15291964
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
Huang C; Huang K; Wang C; Jiang ZD; Li XX; Wang HP; Chen HY
Oncol Rep; 2009 Jul; 22(1):89-95. PubMed ID: 19513509
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of membrane type I matrix metalloproteinase (MT1-MMP) expression with clinicomorphological features of tumor front in squamous cell carcinoma of the larynx].
Starska K; Stasikowska O; Lukomski M; Lewy-Trenda I
Pol Merkur Lekarski; 2007 Sep; 23(135):188-91. PubMed ID: 18080692
[TBL] [Abstract][Full Text] [Related]
14. Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7.
Saussez S; Cludts S; Capouillez A; Mortuaire G; Smetana K; Kaltner H; André S; Leroy X; Gabius HJ; Decaestecker C
Int J Oncol; 2009 Feb; 34(2):433-9. PubMed ID: 19148478
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma.
Charous SJ; Stricklin GP; Nanney LB; Netterville JL; Burkey BB
Ann Otol Rhinol Laryngol; 1997 Apr; 106(4):271-8. PubMed ID: 9109715
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions.
Peschos D; Damala C; Stefanou D; Tsanou E; Assimakopoulos D; Vougiouklakis T; Charalabopoulos K; Agnantis NJ
Histol Histopathol; 2006 Jun; 21(6):603-8. PubMed ID: 16528670
[TBL] [Abstract][Full Text] [Related]
17. Serum Level of Matrix Metalloproteinase-9 in Patients with Head and Neck Squamous Cell Carcinoma.
Stanciu AE; Zamfir-Chiru-Anton A; Stanciu MM; Popescu CR; Gheorghe DC
Clin Lab; 2016 Aug; 62(8):1569-1574. PubMed ID: 28164611
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
19. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas.
Görögh T; Beier UH; Bäumken J; Meyer JE; Hoffmann M; Gottschlich S; Maune S
Head Neck; 2006 Jan; 28(1):31-9. PubMed ID: 16265652
[TBL] [Abstract][Full Text] [Related]
20. Involvement of focal adhesion kinase in cellular proliferation, apoptosis and prognosis of laryngeal squamous cell carcinoma.
Li DW; Sun YJ; Sun ZF; Dong P
J Laryngol Otol; 2012 Nov; 126(11):1127-33. PubMed ID: 22963761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
